VY NGUYEN: Open Payments
NPI 1619520038 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,036 in 68 payments from 13 companies in 2025. Trend: 2023 $1,566 · 2024 $1,239 · 2025 $2,036
Food & beverage: $2,036
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $383 |
| Janssen Pharmaceuticals, Inc | 5 | $263 |
| Axsome Therapeutics, Inc. | 7 | $262 |
| HARMONY BIOSCIENCES LLC | 12 | $259 |
| Tris Pharma Inc | 2 | $250 |
| Supernus Pharmaceuticals, Inc. | 7 | $155 |
| JAZZ PHARMACEUTICALS INC. | 5 | $148 |
| ABBVIE INC. | 6 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
Products named: REXULTI, SPRAVATO, Auvelity, WAKIX, Dyanavel XR, Qelbree, VRAYLAR, RYLAZE.
Industry payments across TX — which companies pay providers there.
